Generic Flomax Approved for Enlarged Prostate

A common condition in older men

TUESDAY, March 2 (HealthDay News) -- The first generic version of Flomax (tamsulosin hydrochloride) capsules has been approved by the U.S. Food and Drug Administration to treat benign prostatic hyperplasia (BPH), the medical term for an enlarged prostate.

California-based IMPAX Laboratories will be producing the generic version, which will have the same prescribing information and safety warnings as the brand-name capsules, the FDA said in a news release.

Advertisement

Related Stories • Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study • Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study Shows • U.S. Cancer Death Rate Keeps Falling: Report Related Videos No More Biopsies? Controlling Incontinence Lycopene For Prostate Cancer Related Slides Prostate Cancer Benign Prostate Hyperplasia

BPH affects more than half of men in their 60s and as many as 90 percent of men older than 70, the agency said. Common symptoms include weak urine stream, urgency, leaking or dribbling, and more frequent urination -- often at night.

More information

To learn more about enlarged prostate, visit the U.S. National Kidney and Urologic Diseases Information Clearinghouse.